Surya Pharmaceutical (Delisted) share news and announcements
BSE: 532516
Last traded ₹0.15 on 14 Sep 2015
Delisted on 11 May 2018.
Surya Pharmaceutical share news and announcements
400 announcements, routine notices left out, newest first. Page 5 of 8.
May 2012
22 May · Limited Review for March 31, 2012
16 May · Management
Dr. R.K Gupta & Dr. H.B.L Vohra have resigned from the directorship of the Company.15 May · Management
Dr. R. K. Gupta & Dr. H. B. L. Vohra have resigned from the directorship of the Company.8 May · Board meeting
To take on record the un-audited Financial Results (Provisional) of the Company for the quarter ended March 31, 2012 along with Limited Review Report thereon.2 May · Management
(1) The Company has shifted its Registered Office from # 601, 6th Floor, Surya Kiran Building, 19, K.G Marg, Connaught Place, New Delhi - 110001 TO 1596 ,Floor 1st, Bhagirath Palace, Delhi with effect from April 27, 2012.(2) Dr. S.K.Yadav has been appointed as Additional Director of the company w.e.f. April 27, 2012..2 May · Management
Following: 1. The Company has shifted its Registered Office from # 601, 6th Floor, Surya Kiran Building, 19, K. G. Marg, Connaught ....
Apr 2012
19 Apr · Updates
1. The State Bank of India as the lead bank of the consortium of bankers of Surya Pharmaceutical Limited has referred the Company ....19 Apr · Updates
(1) The State Bank of India as the lead bank of the consortium of bankers of Surya Pharmaceutical Limited has referred the Company for restructuring of its debt to the Corporate Debt Restructuring Cell, Mumbai and the Company has been admitted by CDR Cell with the support of majority of lenders; (2) The Company has received Certificate of Suitability (COS) for Cefalexin Monohydrate from European Directorate for the Quality of Medicines (EDQM), in addition to already approved Cefixime. Further, the Company's Banur Plant has also been approved by Teva for the supply of Intermediates. These developments and the expected approvals from USFDA/TGA/MCA/MCC will help the Company service its debt obligation post restructuring.
Mar 2012
6 Mar · Address Change
Company has shifted its Registered Office from # 911, 9th Floor, Surya Kiran Building, 19 K.G. Marg, Connaught Place, New Delhi - 110001 to # 601, 6th Floor, Surya Kiran Building, 19 K.G. Marg, Connaught Place, New Delhi - 110001 with effect from March 01, 2012..5 Mar · Change of Place of Registered Officer
Company has shifted its Registered Office from # 911, 9th Floor, Surya Kiran Building, 19 K.G. Marg, Connaught Place, New Delhi - 110001 ....
Feb 2012
13 Feb · Board meeting
Board of Directors of the Company at its meeting held on February 11, 2012, Mr . Devinder Pal has resigned from the directorship of the Company. The Board has appointed Mr. Sanjay S. kumar as Nominee Director-IDBI Bank in place of Mr. Ashwani kumar Agarwal.13 Feb · Board meeting
Board of Directors of the Company at its meeting held on February 11, 2012, inter alia, Mr. Devinder Pal has resigned from the directorship ....1 Feb · Board meeting
To take on record the Un-audited Financial Results (Provisional) of the Company for the quarter ended December 31, 2011 along with Limited Review Report thereon.
Dec 2011
Nov 2011
14 Nov · Management
At the meeting of the Board of Directors of the Company held on November 12, 2011, Mr. Anil Arya & Mr. Abhishek Arya have resigned from the directorship of the Company w.e.f. November 12, 2011. The Board has appointed Mr. D.P. Singhal as Independent Additional Director of the Company.